Dr. Alberto Santoro is a Professor in the Department of Surgical Sciences at Sapienza University of Rome and also as a medical referent for clinical trial center. He was graduated in Medicine and Surgery at the University of Rome. He has received numerous awards for his profession and skills and was honored with the title "Duke of ecclesiastical ducal nobility". He was awarded the title "Academician of merit" by the Accademia Angelica Costantiniana. He has been a rapporteur at numerous national and international congresses in the field of surgery.He is also a member of Internalization comitee in Sapienza-University of Rome.
Dr. Alberto Santoro is a Professor in the Department of Surgical Sciences at Sapienza University of Rome and also as a medical referent for clinical trial center. He was graduated in Medicine and Surgery at the University of Rome. He has received numerous awards for his profession and skills and was honored with the title "Duke of ecclesiastical ducal nobility". He was awarded the title "Academician of merit" by the Accademia Angelica Costantiniana. He has been a rapporteur at numerous national and international congresses in the field of surgery.He is also a member of Internalization comitee in Sapienza-University of Rome. He also serves in the Department of Surgical Sciences.
Dr. Christian F Singer is a Professor of Clinical-Translational Gynecological Oncology, Medical University of Vienna and Head for the Center for Hereditary Breast and Ovarian Cancer, General Hospital of Vienna. He received his Master of Public Health Graduate Program at Harvard University, USA. He served as an Deputy Head, Center for Breast Health, MUV - General Hospital of Vienna. He was honored with Award of the Austrian Society for Senology, Researcher of the Month, Medical University of Vienna etc. He is a member in Austrian Society of Obstetrics and Gynecology (OEGGG), Austrian Society of Senology (OGS) etc. His research interests
Dr. Christian F Singer is a Professor of Clinical-Translational Gynecological Oncology, Medical University of Vienna and Head for the Center for Hereditary Breast and Ovarian Cancer, General Hospital of Vienna. He received his Master of Public Health Graduate Program at Harvard University, USA. He served as an Deputy Head, Center for Breast Health, MUV - General Hospital of Vienna. He was honored with Award of the Austrian Society for Senology, Researcher of the Month, Medical University of Vienna etc. He is a member in Austrian Society of Obstetrics and Gynecology (OEGGG), Austrian Society of Senology (OGS) etc. His research interests include center around breast cancer and BRCA1 and 2.
Dr. Patrizia Ferroni is a Professor in the Department of Human Sciences and Quality of Life Promotion at San Raffaele Roma Open University, Italy. She is working as an Senior Research Consultant in IRCCS san Raffaele Pisana. She received her PhD from Sapienze Rome University. Her technical skills and competencies includes development of immunoassays for the detection of tumor associated antigens (TAA) in tissues, plasma and other body fluids, development of immunoassays to support clinical studies for evaluating the efficacy of MAbs to detect carcinomas as well as deliver therapeutic agents. She is a member of several national and international
Dr. Patrizia Ferroni is a Professor in the Department of Human Sciences and Quality of Life Promotion at San Raffaele Roma Open University, Italy. She is working as an Senior Research Consultant in IRCCS san Raffaele Pisana. She received her PhD from Sapienze Rome University. Her technical skills and competencies includes development of immunoassays for the detection of tumor associated antigens (TAA) in tissues, plasma and other body fluids, development of immunoassays to support clinical studies for evaluating the efficacy of MAbs to detect carcinomas as well as deliver therapeutic agents. She is a member of several national and international scientific societies- International society on Thrombosis and Haemostasis (ISTH), European Association for Cancer research (EACR) and Italian society of Internal Medicine (SIMI). Her scientific research includes thrombosis issues in solid cancer, with special reference to new diagnostic/prophylaxis strategies for venous thromoboembolism and the use and construction of innovative platforms to imporve health care organisation and efficiency.
Dr. Antonio Russo is a Professor in the Department of Surgical, Oncological and Stomatological Sciences. He worked as an Adjunct Associate Professor in the Temple University's College of Science and Technology, Philadelphia,Pennsylvania,USA. He served as an Director of the Specialization School in Medical Oncology, University of Palermo, Italy. The Medical Oncology Unit directed by Prof. A Russo has been recognized as a ESMO Designated Centres of Integrated Oncology and Palliative Care. His areas of expertise includes Design and conduction of phase II-III clinical trials in solid tumours, Chemotherapy and targeted therapies of solid tumors etc. He was awarded with the
Dr. Antonio Russo is a Professor in the Department of Surgical, Oncological and Stomatological Sciences. He worked as an Adjunct Associate Professor in the Temple University's College of Science and Technology, Philadelphia,Pennsylvania,USA. He served as an Director of the Specialization School in Medical Oncology, University of Palermo, Italy. The Medical Oncology Unit directed by Prof. A Russo has been recognized as a ESMO Designated Centres of Integrated Oncology and Palliative Care. His areas of expertise includes Design and conduction of phase II-III clinical trials in solid tumours, Chemotherapy and targeted therapies of solid tumors etc. He was awarded with the Specialist in Medical Genetics in the University of Catania, Italy.
Dr.Kyu Lim is a Professor in the Department of Biochemistry at the National University School of Medicine South Korea. He is graduated at Yeongnam University College of Pharmacy in the year 1987. He worked as an Chairman from 1992-2005. He was an Associate professor and also an Visiting Professor on Inflammation and Cancer including Omega-3 fatty acid and Cancer etc. His research includes: identify novel molecular mechanisms of anti-cancer action of omege-3 fatty acids, inflammation and cancer, overcome of chemotherapeutic drugs resistance in cancer cells, regulation of gene expression on metastasis and angiogenesis related proteins. He was honored for health
Dr.Kyu Lim is a Professor in the Department of Biochemistry at the National University School of Medicine South Korea. He is graduated at Yeongnam University College of Pharmacy in the year 1987. He worked as an Chairman from 1992-2005. He was an Associate professor and also an Visiting Professor on Inflammation and Cancer including Omega-3 fatty acid and Cancer etc. His research includes: identify novel molecular mechanisms of anti-cancer action of omege-3 fatty acids, inflammation and cancer, overcome of chemotherapeutic drugs resistance in cancer cells, regulation of gene expression on metastasis and angiogenesis related proteins. He was honored for health and medical service technology of the minister of health and welfare, and best professor award in his research field.
Dr. Youngjoo Kwon is a Professor in the Department of Pharmaceutical sciences at the college of pharmacy, Ewha Womans University, Korea. She worked as an associate professor in the divison of life and pharmaceutical science in the college of pharmacy. She received her PhD in the analytical chemistry at the university of Houston. She was honored the best poster award of welch foundation, academic advance award of the korean society of applied pharmacology, the first place poster session of houston high field NMR symposium, Structural membership solution to biological system. Her research areas includes Interdisciplinary areas of chemistry and biology,
Dr. Youngjoo Kwon is a Professor in the Department of Pharmaceutical sciences at the college of pharmacy, Ewha Womans University, Korea. She worked as an associate professor in the divison of life and pharmaceutical science in the college of pharmacy. She received her PhD in the analytical chemistry at the university of Houston. She was honored the best poster award of welch foundation, academic advance award of the korean society of applied pharmacology, the first place poster session of houston high field NMR symposium, Structural membership solution to biological system. Her research areas includes Interdisciplinary areas of chemistry and biology, determination of metabolites of drugs and micro-organisms, to determine endogenous metabolic ligands which trigger ROS generation and pathogenic activity by bacteria in Drosophila gut using advanced analytical technology such as NMR, LC-MS/MS, to develop chemical tools for understanding or determination of novels roles of target proteins.
Dr. Sabry Mohamed Attia is a professor in the Department of Pharmacology and Toxicology,College of Pharmacy,King Saud University, Riyadh,Saudi Arabia. He worked as an Assistant Professor in the Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. He received his PhD in Genetics, Technical University of Munich, Germany. Dr. Attia also worked as a postdoctoral fellow at GSF-Institute of Experimental Genetics and Helmholtz ZentrumMunchen-Genome Analysis Center, Germany. He has received grants from federal and local agencies and from various foundations. His scientific career focuses on developing an expertise in several advanced techniques and research protocols related to molecular pharmacology
Dr. Sabry Mohamed Attia is a professor in the Department of Pharmacology and Toxicology,College of Pharmacy,King Saud University, Riyadh,Saudi Arabia. He worked as an Assistant Professor in the Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. He received his PhD in Genetics, Technical University of Munich, Germany. Dr. Attia also worked as a postdoctoral fellow at GSF-Institute of Experimental Genetics and Helmholtz ZentrumMunchen-Genome Analysis Center, Germany. He has received grants from federal and local agencies and from various foundations. His scientific career focuses on developing an expertise in several advanced techniques and research protocols related to molecular pharmacology and toxicology. His patants includes: Novel short-term assays for the detection of mutagenic and carcinogenic chemicals in somatic and germinal cells. He received numerous awards like, Abdul Hameed Shoman Award for Arab Researchers in Medical and Health Sciences-Amman, Jordan, Waleed Kayali Prize for Scientific Research, Saudi Pharmaceutical Society, Riyadh, Saudi Arabia, "State Prize for Encouragement of Scientific Research" in Medical Sciences, the Academy of Scientific Research and Technology, Cairo, Egypt etc. Dr. Attia research field includes Development and evaluate methods for detection of genotoxicant, Determination of the influence of cell cycle checkpoint genes such as p53upon the induction of DNA damage and mechanisms of action, Identification of potential biomarkers of exposure to genotoxicants etc.
Dr. Osamu Tanaka is a Chief professor at Department of Radiation Oncology, Asahi University Hospital and Associate professor in Murakami Memorial Hospital, Gifu, Japan. He served as a Vice Leader of Radiotherapy at Kizawa Memorial Hospital. 2007 - 2015, Fellow doctor of Division of Radiation Therapy, Cancer Institute Hospital, Tokyo, Japan 2006 - 2007, he is a certified Radiation Oncologist (JASTRO). He is a General Cancer Specialist in Japanese Board of Cancer Therapy. He completed MD from Gifu University School of Medicine. He has studied at various university hospitals like Gifu University Hospital, Cancer Institute Hospital and Kizawa Memorial Hospital.
Dr. Osamu Tanaka is a Chief professor at Department of Radiation Oncology, Asahi University Hospital and Associate professor in Murakami Memorial Hospital, Gifu, Japan. He served as a Vice Leader of Radiotherapy at Kizawa Memorial Hospital. 2007 - 2015, Fellow doctor of Division of Radiation Therapy, Cancer Institute Hospital, Tokyo, Japan 2006 - 2007, he is a certified Radiation Oncologist (JASTRO). He is a General Cancer Specialist in Japanese Board of Cancer Therapy. He completed MD from Gifu University School of Medicine. He has studied at various university hospitals like Gifu University Hospital, Cancer Institute Hospital and Kizawa Memorial Hospital. He published more than 39 papers in reputed journals. He has received the Award of Umegaki in 2007 which is given to only one young researcher from Japanese Society of Radiation Oncology Biology and Physics. He is Board member of the Japanese Radiological Society.
Prof. Luisa Tesoriere is a Dean of the School of Pharmacy, University of Palermo, Professor of Biochemistry, School of Pharmacy, University of Palermo and Professor of Molecular Biology, School of Chemistry and Pharmaceutical Technologies, University of Palermo. She is a Patent Inventor. Her patents include Procedure for purifying Raw Manna, Purified Manna and its use. Patent with Ministry of Economic Development (patent102015000061706, UB2015A004662, 6 April 2018). She was graduated in Biology 1980, University of Palermo. She is Author of 120 publications on International journals of Biochemistry and Nutraceutics, co-author of 130 full papers and 15 Chapters in International Books ISBN
Prof. Luisa Tesoriere is a Dean of the School of Pharmacy, University of Palermo, Professor of Biochemistry, School of Pharmacy, University of Palermo and Professor of Molecular Biology, School of Chemistry and Pharmaceutical Technologies, University of Palermo. She is a Patent Inventor. Her patents include Procedure for purifying Raw Manna, Purified Manna and its use. Patent with Ministry of Economic Development (patent102015000061706, UB2015A004662, 6 April 2018). She was graduated in Biology 1980, University of Palermo. She is Author of 120 publications on International journals of Biochemistry and Nutraceutics, co-author of 130 full papers and 15 Chapters in International Books ISBN catalogued. She is a member of Doctoral College of Research of Molecular and Bio-Molecular Science, member of Italian Society of Biochemistry and Moleculat Biology, Biochemistry of Nutrition and member of European Retinoids Research Group. She is a Editor for Magzines British Journal of Nutrition, Phytotherapy Research, Journal of Ethnopharmacology, Journal of Agricultural and Food Chemistry, BioMed Central Complementary and Alternative Medicine. Her Interests are includes nutraceuticals; bioactivity of natural products; betalain pigments; biochemistry; nutritional biochemistry.
Dr. Alessandro Attanzio is a Biochemist in Department of Biological, Chemical and Pharmaceutical Sciences and Technologies - University of Palermo. He completed his PhD in Pharmaceutical Sciences. He is a patent inventor. He is a International Member of the PhD examining committee of International Research in Food Science Departament Preventive Medicine. He was certified as Certificate of participation in ZF-MED Zebrafish and other aquatic models in Mediterranean labs -The Zebrafish model in Biotechnology and Health Sciences, University of Palermo in 2017. He is an author of 42 publications on International journals of Biochemistry and Nutraceutics. He was given
Dr. Alessandro Attanzio is a Biochemist in Department of Biological, Chemical and Pharmaceutical Sciences and Technologies - University of Palermo. He completed his PhD in Pharmaceutical Sciences. He is a patent inventor. He is a International Member of the PhD examining committee of International Research in Food Science Departament Preventive Medicine. He was certified as Certificate of participation in ZF-MED Zebrafish and other aquatic models in Mediterranean labs -The Zebrafish model in Biotechnology and Health Sciences, University of Palermo in 2017. He is an author of 42 publications on International journals of Biochemistry and Nutraceutics. He was given a Theophrastos Prize from the International Pro-Mediterranean Herbarium Foundation 2017 for biochemical studies on organic molecules with nutraceutical effects extracted from Mediterranean plants. His research includes Interests: nutraceuticals; plant extracts; bioactivity of natural products; biochemistry .
Dr. Girja Shukla is an Associate Professor in the Department of Surgery and a Full Member of Cancer Center at the University of Vermont College of Medicine, Burlington, Vermont, USA. He is an Active Member of American Association for Cancer Research & Vermont Cancer Center.He was awarded prestigious National Young Scientist Award of Council of Scientific and Industrial Research (CSIR). He is also an Editorial Board Member of Mutations & Cancer Studies and Journal of Cancer Science & Therapy. His research interest is to develop targeted therapy against breast cancer. It involves in vitro (fresh tumors, cancer cell lines, purified
Dr. Girja Shukla is an Associate Professor in the Department of Surgery and a Full Member of Cancer Center at the University of Vermont College of Medicine, Burlington, Vermont, USA. He is an Active Member of American Association for Cancer Research & Vermont Cancer Center.He was awarded prestigious National Young Scientist Award of Council of Scientific and Industrial Research (CSIR). He is also an Editorial Board Member of Mutations & Cancer Studies and Journal of Cancer Science & Therapy. His research interest is to develop targeted therapy against breast cancer. It involves in vitro (fresh tumors, cancer cell lines, purified cancer targets) and in vivo (animals and cancer patients) selection of tumor targeting agents using phage-displayed peptide, single chain antibody and β-lactamase loop libraries. In addition, Dr. Girja Shukla is also interested in generating cancer-specific full-length human antibodies, using EBV immortalization and hybridoma techniques, from B cells obtained from sentinel nodes, bone marrow aspirates and tumor tissues of cancer patients. Recently, his group has been working on the high throughput immuno-sequencing of B-cell repertoire of tumor and vaccine draining lymph nodes from cancer patients and relevant preclinical models. He is also actively collaborating in several clinical trials being conducted at the University of Vermont, Dartmouth Hitchcock Medical Center, and University of Virginia.
Dr. Maria Diakonova is an Associate Professor in the Department of Biological Science in the University of Toledo, Ohio, USA. She worked as an Assistant Professor in the Department of Biological Science, Ohio. She received her PhD in cell biology in Internalization and intracellular sorting of growth factors receptors, in the Institute of Cytology Russian Academy of Science, St.Petersburg, Russia. Her reaserch field includes a role of prolactin in breast cancer progression, and currently she is focusing on a role PAK1 in prolactin and estrogen signaling. She also demostrated that the serine-threonine kinase PAK1 associates with and is tyrosyl phosphorylated
Dr. Maria Diakonova is an Associate Professor in the Department of Biological Science in the University of Toledo, Ohio, USA. She worked as an Assistant Professor in the Department of Biological Science, Ohio. She received her PhD in cell biology in Internalization and intracellular sorting of growth factors receptors, in the Institute of Cytology Russian Academy of Science, St.Petersburg, Russia. Her reaserch field includes a role of prolactin in breast cancer progression, and currently she is focusing on a role PAK1 in prolactin and estrogen signaling. She also demostrated that the serine-threonine kinase PAK1 associates with and is tyrosyl phosphorylated by prolactin-activated JAK2 kinase to regulate cyclin D1 promoter activity, adhesion, motility and invasiveness of breast cancer cells by multiple mechanisms. She was Honored with a travel grant from FASEB Science Research Conference, Foy & Phyllis Penn Kohler Fund, Russian Foundation for Basic Research to participate in the conference " cellular Programmes for Growth".
Dr. AFM Motiur Rahman is an Associate Professor in College of Pharmacy, King Saud University. He worked as an Assistant Professor in the Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University. Dr. Rahman received his PhD in Pharmaceutical Science from Yeungnam University, South Korea. Two of his research projects were funded by National Plan for Science and Technology, King Abdullah City for Science and Technology, Ministry of Education, Saudi Arabia. Dr. Rahman is an active member of American Society for Mass Spectrometry, Saudi Pharmaceutical Society etc. His current research projects include Design, Synthesis and Biological Evaluation of Diarylheptanoids
Dr. AFM Motiur Rahman is an Associate Professor in College of Pharmacy, King Saud University. He worked as an Assistant Professor in the Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University. Dr. Rahman received his PhD in Pharmaceutical Science from Yeungnam University, South Korea. Two of his research projects were funded by National Plan for Science and Technology, King Abdullah City for Science and Technology, Ministry of Education, Saudi Arabia. Dr. Rahman is an active member of American Society for Mass Spectrometry, Saudi Pharmaceutical Society etc. His current research projects include Design, Synthesis and Biological Evaluation of Diarylheptanoids and Their Derivatives for the Development of New Anti-Cancer Agents etc. Dr. Rahman's research interests focus on Total synthesis of natural products, Bio-conjugates Chemistry, Host-guest chemistry and Heterocyclic Chemistry, Biological activities such as Cytotoxicity, Topoisomerase I & II inhibitory activity, etc.
Dr.Feifei Pu's interest in Degenerative disease of bone and joint, comprehensive treatment of bone tumors . Dr. Feifei Pu is a member of China Association of Traditional Chinese Medicine, using his laboratory, he carried out relevant research on the anti-osteosarcoma of the extract of Oldenlandia diffusa, and extracted a series of active components for further study. Dr.Feifei Pu is the orthopedic doctor and researcher of Wuhan No.1 Hospital, Wuhan Integrated TCM & Western Medicine Hospital, Tongji Medical College, Huazhong University of Science and Technology in China.
Dr.Feifei Pu's interest in Degenerative disease of bone and joint, comprehensive treatment of bone tumors . Dr. Feifei Pu is a member of China Association of Traditional Chinese Medicine, using his laboratory, he carried out relevant research on the anti-osteosarcoma of the extract of Oldenlandia diffusa, and extracted a series of active components for further study. Dr.Feifei Pu is the orthopedic doctor and researcher of Wuhan No.1 Hospital, Wuhan Integrated TCM & Western Medicine Hospital, Tongji Medical College, Huazhong University of Science and Technology in China.
Dr. Marco Agostini is a Research Scientist in the Department of Surgical Oncology and Gastroenterological Science at the University of Padova, Padova, Italy. He worked as an Assistant Professor in the Department of Oncology and Surgical Sciences at the University of Padova, Italy. He received his PhD in genetic and molecular characterization of cancer, with a concentration on the genetic pathways underlying the progression and outcome of colon cancer as well as drug delivery system modulation at the university of Padova, Italy. His research field focuses on Discovery of new molecular markers for the non-invasive (liquid biopsies) early detection of
Dr. Marco Agostini is a Research Scientist in the Department of Surgical Oncology and Gastroenterological Science at the University of Padova, Padova, Italy. He worked as an Assistant Professor in the Department of Oncology and Surgical Sciences at the University of Padova, Italy. He received his PhD in genetic and molecular characterization of cancer, with a concentration on the genetic pathways underlying the progression and outcome of colon cancer as well as drug delivery system modulation at the university of Padova, Italy. His research field focuses on Discovery of new molecular markers for the non-invasive (liquid biopsies) early detection of cancer, and identifying the roles of circulating molecular markers in pathologic tumor responses and rectal cancer patient outcome after receiving pre-operative chemoradiotherapy, circulating miRNA, peptidome. Dr. Marco Agostini patent includes Invitro method for the diagnosis, prognosis and treatment of cancer through the analysis in a body fluid sample of the total circulating DNA and the amount of DNA released by non-apoptic cells, etc.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97